The company "group" exchange safety risk management and control experience
Release time:
2020-10-09
Company "organized" to exchange safety risk control experience
News from our newspaper 9# May 24 and 25 , the group company's safety risk control work seminar was held at Daye Peak. More than ten persons in charge of production safety from the group company and its subordinate enterprises visited the site, shared their experiences, and jointly discussed the work of safety risk management and control. On the afternoon of
24, while visiting Daye Peak Factory, the participants also conducted a comprehensive inspection of the production site to check hidden dangers and find problems. The seminar on
25was presided over by Chen Tianci, chairman of the board of supervisors of the group company. Zhang Fengliang, deputy general manager of the group company and general manager of Daye Peak, Li Xiaoyin, safety director of the group company, and leaders and safety directors of various professional companies and directly affiliated enterprises participated in the discussion. Wu Xinqiong, deputy manager of Daye Peak Environmental Security Department, reported on the learning results of his previous trip to Lafarge, Guizhou, and introduced Daye Peak's experience and effectiveness in implementing operational risk assessment and safety performance cards. The heads of Daye Peak Manufacturing Department, Packaging System and Inspection Class respectively introduced the application experience of the "Operation Risk Assessment Form" and the employees' response to the safety performance card evaluation. After nearly half a year of operation, the employees generally responded well.
As the promoter of Lafarge's safety management model in Daye Peak, Zhang Fengliang shared Daye Peak's experience in learning advanced experience: first of all, it is necessary to change concepts, unify ideological understanding, attach importance to safety risk assessment, and establish a reward mechanism; Secondly, we should attach importance to the role of team leaders and improve the risk assessment ability and comprehensive safety quality of employees through the filling in the Operation Risk Assessment Form. To systematically do a good job of safety management, safety standardization "13 elements" as a guide to safety management. He believes that filling in the "Operation Risk Assessment Form" is not only the safety control of the operation, but also the control of the maintenance process and quality, so that safety assurance measures can be integrated with production and operation.While exchanging experience in safety risk management and control, the safety management personnel of participating brother units also put forward suggestions for improvement on the problems existing in the on-site inspection of Daye Peak. Li Xiaoyin made a comprehensive summary and analysis of the company's safety management and accidents this year. At the
seminar, Chen Tianci affirmed the safety management effectiveness of Daye Peak, and hoped that Daye Peak would continue to work hard to further improve the safety risk assessment management system, humbly accept the opinions and suggestions put forward by brother units, and improve in future work.
In view of the company's subordinate enterprises learning and implementing safety management experience in benchmarking advanced enterprises, Chen Tianci proposed to attach importance to the "ritual sense" of safety management, formulate "Safety Instructions for Entry into the Factory", and do a good job in safety education and training for foreign personnel. Put the "Health and Safety Regulations" on the wall in a prominent position of the company so that every employee can see them frequently and alert them at all the time; it is necessary to check and fill gaps in the safety management work against the "thirteen elements" of safety management. The system is not perfect and the system is required to strengthen inspection and supervision. He asked all units to complete their respective risk assessment implementation plans between October
and 11 while learning the work experience of Daye peak safety risk assessment, and to carry out internal review and publicity, and to implement them within all enterprises before the end of 12 , making continuous efforts to achieve the safety management objectives for the whole year. (Wang Yuhua Wu Xinqiong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page